Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa.

Hunt GM, Dokubo EK, Takuva S, de Oliveira T, Ledwaba J, Dube N, Moodley P, Sabatier J, Deyde V, Morris L, Raizes E.

J Antimicrob Chemother. 2017 Nov 1;72(11):3141-3148. doi: 10.1093/jac/dkx252.

PMID:
28981637
2.

Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa.

Hunt GM, Kainne Dokubo E, Takuva S, de Oliveira T, Ledwaba J, Dube N, Moodley P, Sabatier J, Deyde V, Morris L, Raizes E.

J Antimicrob Chemother. 2017 Nov 1;72(11):3222. doi: 10.1093/jac/dkx340. No abstract available.

PMID:
28961961
3.

An association between decreasing incidence of invasive non-typhoidal salmonellosis and increased use of antiretroviral therapy, Gauteng Province, South Africa, 2003-2013.

Keddy KH, Takuva S, Musekiwa A, Puren AJ, Sooka A, Karstaedt A, Klugman KP, Angulo FJ.

PLoS One. 2017 Mar 6;12(3):e0173091. doi: 10.1371/journal.pone.0173091. eCollection 2017.

4.

The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90-90-90 targets.

Takuva S, Brown AE, Pillay Y, Delpech V, Puren AJ.

AIDS. 2017 Feb 20;31(4):545-552. doi: 10.1097/QAD.0000000000001340.

PMID:
28121668
5.

Prevalence of common vitamin D receptor gene polymorphisms in HIV-infected and uninfected South Africans.

McNamara L, Takuva S, Chirwa T, MacPhail P.

Int J Mol Epidemiol Genet. 2016 Mar 23;7(1):74-80. eCollection 2016.

6.

Decline in syphilis seroprevalence among females of reproductive age in Northern Cape Province, South Africa, 2003-2012: utility of laboratory-based information.

Ballah NJ, Kuonza LR, De Gita G, Musekiwa A, Williams S, Takuva S.

Int J STD AIDS. 2017 May;28(6):564-572. doi: 10.1177/0956462416636727. Epub 2016 Feb 27.

7.

Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010.

Ndlovu Z, Chirwa T, Takuva S.

Pan Afr Med J. 2014 Oct 1;19:114. doi: 10.11604/pamj.2014.19.114.3600. eCollection 2014.

8.

Etiology and antimicrobial susceptibility of pathogens responsible for urethral discharge among men in Harare, Zimbabwe.

Takuva S, Mugurungi O, Mutsvangwa J, Machiha A, Mupambo AC, Maseko V, Cham F, Mungofa S, Mason P, Lewis DA.

Sex Transm Dis. 2014 Dec;41(12):713-7. doi: 10.1097/OLQ.0000000000000204.

PMID:
25581806
9.

Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort.

Takuva S, Maskew M, Brennan AT, Long L, Sanne I, Fox MP.

J Int AIDS Soc. 2014 Mar 3;17:18651. doi: 10.7448/IAS.17.1.18651. eCollection 2014.

10.

Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen.

Takuva S, Maskew M, Brennan AT, Sanne I, Macphail AP, Fox MP.

J Trop Med. 2013;2013:162950. doi: 10.1155/2013/162950. Epub 2013 Aug 27.

11.

Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults.

Takuva S, Evans D, Zuma K, Okello V, Louwagie G.

Pan Afr Med J. 2013 May 3;15:5. doi: 10.11604/pamj.2013.15.5.1889. Print 2013.

12.

High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients.

Swart M, Skelton M, Ren Y, Smith P, Takuva S, Dandara C.

Pharmacogenet Genomics. 2013 Aug;23(8):415-27. doi: 10.1097/FPC.0b013e328363176f.

PMID:
23778320
13.

HIV-associated lipodystrophy in South Africa: the impact on the patient and the impact on the plastic surgeon.

Zinn RJ, Serrurier C, Takuva S, Sanne I, Menezes CN.

J Plast Reconstr Aesthet Surg. 2013 Jun;66(6):839-44. doi: 10.1016/j.bjps.2013.02.032. Epub 2013 Mar 30.

PMID:
23545227
14.

Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses.

Takuva S, Westreich D, Menezes CN, McNamara L, Sanne I, Page-Shipp L, Maskew M.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1358-64. doi: 10.5588/ijtld.11.0769. Epub 2012 Aug 3.

15.

Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.

Evans D, Takuva S, Rassool M, Firnhaber C, Maskew M.

J Neurovirol. 2012 Jun;18(3):162-71. doi: 10.1007/s13365-012-0093-2. Epub 2012 Apr 20.

PMID:
22528477

Supplemental Content

Loading ...
Support Center